m+Medelevator.RU
← Поиск публикаций
Folia phoniatrica et logopaedica : official organ of the International Association of Logopedics and Phoniatrics (IALP) · 2025

Effects of Microwave Ablation Treatment on Voice in Benign Thyroid Nodules and Parathyroid Adenomas.

СтатьяНазвание и аннотация: Перевод в очереди
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

İnceoğlu Özgün Ozan, Türe Nurullah, Korkmaz Mehmet, Aydın Bünyamin

Аннотация

INTRODUCTION: This study investigates the effects of microwave ablation (MWA) on voice in patients with benign thyroid nodules (BTNs) and parathyroid adenomas (PTAs).

METHODS: Patients with BTNs or PTAs who underwent MWA treatment were included. All patients had videolaryngostroboscopic (VLS) examinations, GRBAS assessments, patient-reported outcomes (Turkish Voice Handicap Index-10 [T-VHI-10] and Turkish Voice-Related Quality of Life [T-VRQOL] scales), and acoustic analysis before treatment. Evaluations were repeated at 1 week and 3 months post-procedure.

RESULTS: For BTNs, subjective evaluations showed significant improvements in GRBAS total scores (p < 0.001) and patient-reported outcomes (T-VHI-10, p = 0.006; T-VRQOL, p = 0.010) at 3 months compared to pretreatment. For PTAs, GRBAS total scores increased significantly in the first week (p = 0.001) but were improved by the third month relative to baseline. Acoustic analysis revealed a significant improvement in jitter (%) values for BTNs between pretreatment and 1 week posttreatment (p = 0.005). Shimmer %, F0 (fundamental frequency), and harmonic-to-noise ratio (HNR) remained stable in BTNs (p = 0.421, 0.134, 0.637), while no significant changes in jitter %, shimmer %, F0, or HNR were observed in PTAs (p = 0.529, 0.895, 0.931, 0.975).

CONCLUSION: Subjective assessment results showed significant improvements (GRBAS, T-VHI-10, T-V-RQOL) for BTNs between pretreatment and 3 months posttreatment. For PTAs, GRBAS total scores at 3 months were better than pretreatment. No significant changes were found in patient-reported measurement scores (T-VHI-10, T-V-RQOL) in patients with PTAs. MWA treatment in patients with BTNs positively affected voice by significantly reducing jitter (%), whereas in PTAs, acoustic analysis indicated no significant voice changes.

Предметные рубрики MeSH

ИП Урсолов Владлен Сергеевич

ИНН 500118482352 · ОГРНИП 314500117700049

Реквизиты и контакты